Form 4: Palisade Bio Director Acquires Shares
Insider Transaction Report
Robert Baltera Jr., a Director at Palisade Bio, Inc., has acquired 30,000 shares of common stock through open market purchases.
Summary
- Robert Baltera Jr., a Director of Palisade Bio, Inc. (PALI), reported the acquisition of 30,000 shares of common stock.
- The transactions occurred on July 1, 2026, and July 2, 2026.
- The shares were purchased at a weighted average price of $1.98 per share, with individual transactions ranging from $1.97 to $1.99.
- Following these acquisitions, Baltera Jr. beneficially owns 366,904 shares of common stock.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive filing due to the director's direct investment in the company's stock, signaling confidence.
Positives
- Director's increased beneficial ownership in the company.
- Acquisition of shares through open market purchases indicates confidence in the company's value.
- The purchase price reflects a potentially attractive valuation for the stock.
Future Outlook
No specific forward-looking statements or guidance are provided in this Form 4 filing, which solely reports on past transactions.
Industry Context
StockSavvy.ai notes that insider buying, particularly by directors, is often interpreted as a positive signal by the market, suggesting a belief in the company's future prospects. This filing indicates a direct investment by a key insider.
Stakeholder Impact
- Shareholders may view this as a positive signal of insider confidence, potentially influencing investment decisions.
- The increased beneficial ownership by a director could be seen as a commitment to the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | Earliest transaction date reported and date of first share acquisition. |
| 07/02/2026 | Date of second share acquisition. |
| 07/06/2026 | Date of signature on the filing. |
Recommendation
holdThis filing reports an insider purchase, which is generally a positive indicator. However, without broader financial context or company performance data, a 'hold' recommendation is prudent, suggesting investors monitor further developments.
Keywords
Palisade Bio, PALI, Form 4, Insider Trading, Stock Acquisition, Director Purchase, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.